Filing Details
- Accession Number:
- 0001127602-12-011929
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-27 15:58:17
- Reporting Period:
- 2012-03-23
- Filing Date:
- 2012-03-27
- Accepted Time:
- 2012-03-27 15:58:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1320940 | B William Hayes | 531 South Spring Street Burlington NC 27215 | Chief Financial Officer, Evp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-03-23 | 30,367 | $60.04 | 58,932 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-03-23 | 41,716 | $70.15 | 100,648 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-23 | 16,707 | $88.67 | 83,941 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-03-23 | 59,863 | $89.96 | 24,078 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2012-03-23 | 30,367 | $0.00 | 30,367 | $60.04 |
| Common Stock | Non-qualified Stock Options | Disposition | 2012-03-23 | 41,716 | $0.00 | 41,716 | $70.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-02-10 | 2019-02-10 | No | 4 | M | Direct |
| 24,984 | 2011-02-09 | 2020-02-09 | No | 4 | M | Direct |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The price of $88.6712 per share represents a weighted average of sales prices ranging from $88.40 to $88.99 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $89.9621 per share represents a weighted average of sales prices ranging from $89.62 to $90.27 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Common stock purchase option granted under the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- The option vests in three equal annual installments beginning on the date reflected in this column.
Billionaire Hedge Funds
